BICO Group AB (CHIX:BICOS) Defensive Interval Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:BICOS BICO Group AB CHIX:BICOS
69 GF Score
Price kr45.75
GF Value kr99.31
! 4 Warning Signs
View Full Analysis

What is BICO Group AB Defensive Interval Ratio?

CHIX:BICOS
69GF Score
BICO Group AB CHIX:BICOS
Defensive Interval Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BICO Group AB (CHIX:BICOS) Overvalued in 2026?

Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued. The current stock price of kr45.75 is trading 53.9% below its estimated GF Value™ of kr99.31.

Key valuation signals for CHIX:BICOS:

  • Defensive Interval Ratio:
  • GF Value™: kr99.31 vs. price of kr45.75 (53.9% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the CHIX:BICOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BICO Group AB Business Description

Address Grafiska vagen 2B, Gothenburg, SWE, 412 63
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
69GF Score

Get the complete analysis for CHIX:BICOS

Defensive Interval Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr45.75
Price
kr99.31
GF Value